Mass Balance, Routes of Excretion, and Pharmacokinetics of Investigational Oral [14C]-Alisertib (MLN8237), an Aurora A Kinase Inhibitor in Patients with Advanced Solid Tumors.
Investigational new drugs（2018）
关键词
Alisertib,Mass balance,Pharmacokinetics,Aurora A kinase
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要